900000000000509007: United States of America English language reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Language type reference set (foundation metadata concept)\English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)\US English

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
US English	Is a	English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	acceptabilityId
17beta-Hydroxyandrost-4-en-3-one decanoate	Acceptable (foundation metadata concept)
17p partial trisomy syndrome	Preferred (foundation metadata concept)
17p partial trisomy syndrome (disorder)	Preferred (foundation metadata concept)
17p11.2 microduplication syndrome	Preferred (foundation metadata concept)
17p11.2 microduplication syndrome (disorder)	Preferred (foundation metadata concept)
17p11.2p12 microduplication syndrome	Acceptable (foundation metadata concept)
17p13.3 microduplication syndrome	Preferred (foundation metadata concept)
17p13.3 microduplication syndrome (disorder)	Preferred (foundation metadata concept)
17q partial trisomy syndrome	Preferred (foundation metadata concept)
17q partial trisomy syndrome (disorder)	Preferred (foundation metadata concept)
17q11 deletion syndrome	Preferred (foundation metadata concept)
17q11 deletion syndrome (disorder)	Preferred (foundation metadata concept)
17q11 microdeletion syndrome is a rare severe form of neurofibromatosis type 1 characterized by mild facial dysmorphism, developmental delay, intellectual disability, increased risk of malignancies, and a large number of neurofibromas.	Preferred (foundation metadata concept)
17q11.2 microduplication syndrome	Preferred (foundation metadata concept)
17q11.2 microduplication syndrome (disorder)	Preferred (foundation metadata concept)
17q12 duplication syndrome	Acceptable (foundation metadata concept)
17q12 microdeletion syndrome	Preferred (foundation metadata concept)
17q12 microdeletion syndrome (disorder)	Preferred (foundation metadata concept)
17q12 microduplication syndrome	Preferred (foundation metadata concept)
17q12 microduplication syndrome (disorder)	Preferred (foundation metadata concept)
17q21.31 microduplication syndrome	Preferred (foundation metadata concept)
17q21.31 microduplication syndrome (disorder)	Preferred (foundation metadata concept)
17q23.1-q23.2 duplication syndrome	Preferred (foundation metadata concept)
17q23.1-q23.2 duplication syndrome (disorder)	Preferred (foundation metadata concept)
17q23.1q23.2 microdeletion syndrome	Preferred (foundation metadata concept)
17q23.1q23.2 microdeletion syndrome (disorder)	Preferred (foundation metadata concept)
17q24-qter duplication syndrome	Preferred (foundation metadata concept)
17q24-qter duplication syndrome (disorder)	Preferred (foundation metadata concept)
17q24.2 microdeletion syndrome	Preferred (foundation metadata concept)
17q24.2 microdeletion syndrome (disorder)	Preferred (foundation metadata concept)
18	Preferred (foundation metadata concept)
18	Acceptable (foundation metadata concept)
18 (qualifier value)	Preferred (foundation metadata concept)
18 lead electrocardiographic monitoring	Preferred (foundation metadata concept)
18 lead electrocardiographic monitoring (procedure)	Preferred (foundation metadata concept)
18 month exam not offered	Acceptable (foundation metadata concept)
18 month exam. not attended	Preferred (foundation metadata concept)
18 month exam. not attended (situation)	Preferred (foundation metadata concept)
18 month exam. not offered	Preferred (foundation metadata concept)
18 month exam. not offered (situation)	Preferred (foundation metadata concept)
18 month exam. not wanted	Preferred (foundation metadata concept)
18 month exam. not wanted (situation)	Preferred (foundation metadata concept)
18 month examination abnormal - for observation	Preferred (foundation metadata concept)
18 month examination abnormal - for observation	Preferred (foundation metadata concept)
18 month examination abnormal - for observation (finding)	Preferred (foundation metadata concept)
18 month examination abnormal - for observation (finding)	Preferred (foundation metadata concept)
18 month examination abnormal - on treatment	Preferred (foundation metadata concept)
18 month examination abnormal - on treatment	Preferred (foundation metadata concept)
18 month examination abnormal - on treatment (finding)	Preferred (foundation metadata concept)
18 month examination abnormal - on treatment (finding)	Preferred (foundation metadata concept)
18 month examination abnormal - referred	Preferred (foundation metadata concept)
18 month examination abnormal - referred	Preferred (foundation metadata concept)
18 month examination abnormal - referred (finding)	Preferred (foundation metadata concept)
18 month examination abnormal - referred (finding)	Preferred (foundation metadata concept)
18 month examination normal	Preferred (foundation metadata concept)
18 month examination normal	Preferred (foundation metadata concept)
18 month examination normal (finding)	Preferred (foundation metadata concept)
18 month examination normal (finding)	Preferred (foundation metadata concept)
18 month examination not attended	Preferred (foundation metadata concept)
18 month examination not attended (situation)	Preferred (foundation metadata concept)
18 month examination not offered	Preferred (foundation metadata concept)
18 month examination not offered (situation)	Preferred (foundation metadata concept)
18 month examination not wanted	Preferred (foundation metadata concept)
18 month examination not wanted (situation)	Preferred (foundation metadata concept)
18,21-dihydroxypregn-4-ene-3,20-dione	Acceptable (foundation metadata concept)
18-F	Acceptable (foundation metadata concept)
18-Hydroxycorticosterone dehydrogenase deficiency	Preferred (foundation metadata concept)
18-Hydroxycorticosterone dehydrogenase deficiency	Acceptable (foundation metadata concept)
18-Hydroxycorticosterone dehydrogenase deficiency (disorder)	Preferred (foundation metadata concept)
18-Hydroxycorticosterone measurement	Preferred (foundation metadata concept)
18-Hydroxycorticosterone measurement (procedure)	Preferred (foundation metadata concept)
18-Hydroxycortisol measurement	Preferred (foundation metadata concept)
18-Hydroxycortisol measurement (procedure)	Preferred (foundation metadata concept)
18-Hydroxydeoxycorticosterone measurement	Preferred (foundation metadata concept)
18-Hydroxydeoxycorticosterone measurement (procedure)	Preferred (foundation metadata concept)
18-Hydroxydeoxycortisol measurement	Preferred (foundation metadata concept)
18-Hydroxydeoxycortisol measurement (procedure)	Preferred (foundation metadata concept)
18-Hydroxylase deficiency	Acceptable (foundation metadata concept)
18-beta glycyrrhetinate	Preferred (foundation metadata concept)
18-beta glycyrrhetinate (substance)	Preferred (foundation metadata concept)
18-hydroxy-corticosteroid	Acceptable (foundation metadata concept)
18-hydroxy-corticosteroids measurement	Preferred (foundation metadata concept)
18-hydroxy-corticosteroids measurement (procedure)	Preferred (foundation metadata concept)
18-hydroxycorticosteroid	Preferred (foundation metadata concept)
18-hydroxycorticosteroid (substance)	Preferred (foundation metadata concept)
18-hydroxycorticosterone	Preferred (foundation metadata concept)
18-hydroxycorticosterone (substance)	Preferred (foundation metadata concept)
18-hydroxycortisol	Preferred (foundation metadata concept)
18-hydroxycortisol (substance)	Preferred (foundation metadata concept)
18-hydroxycortisone	Preferred (foundation metadata concept)
18-hydroxycortisone (substance)	Preferred (foundation metadata concept)
18-hydroxydeoxycorticosterone	Preferred (foundation metadata concept)
18-hydroxydeoxycorticosterone (substance)	Preferred (foundation metadata concept)
18-hydroxydeoxycortisol	Preferred (foundation metadata concept)
18-hydroxydeoxycortisol (substance)	Preferred (foundation metadata concept)
18-hydroxylase	Acceptable (foundation metadata concept)
18-p syndrome with associated immunodeficiency	Acceptable (foundation metadata concept)
18-p syndrome with associated immunodeficiency (disorder)	Preferred (foundation metadata concept)
18.2	Preferred (foundation metadata concept)
18.2 (qualifier value)	Preferred (foundation metadata concept)
18.5	Preferred (foundation metadata concept)

Start Previous Page 75 of 12832 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001115012	United States of America English language reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001116013	US English	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001117016	United States of America English language reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)